Videos / Olopatadine hydrochloride & mometasone furoate combination nasal spray for allergic rhinitis & rhinoconjunctivitis
In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).
This Product Explainer is supported by CSL Seqirus
Heart Failure – Assessment and Monitoring in Primary Care
Heart Failure – Demystifying Pharmacological Management for GPs
COPD Update
Iron Deficiency in Children & Young People
expert
Rhinologist; Nose, Sinus, Allergy and Endoscopic Sinus and Skull Base Surgeon